USA - New York Stock Exchange - NYSE:MD - US58502B1061 - Common Stock
The current stock price of MD is 22.34 USD. In the past month the price increased by 4.49%. In the past year, price increased by 79.58%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.72 | 101.94B | ||
| CI | THE CIGNA GROUP | 9.82 | 74.52B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 124.05 | 22.82B | ||
| LH | LABCORP HOLDINGS INC | 15.92 | 20.88B | ||
| DGX | QUEST DIAGNOSTICS INC | 17.87 | 19.40B | ||
| GH | GUARDANT HEALTH INC | N/A | 14.19B | ||
| DVA | DAVITA INC | 12.07 | 7.87B | ||
| HIMS | HIMS & HERS HEALTH INC | 58.69 | 7.21B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 36.79 | 6.77B | ||
| CHE | CHEMED CORP | 20.2 | 6.29B | ||
| RDNT | RADNET INC | 205.79 | 6.03B | ||
| OPCH | OPTION CARE HEALTH INC | 21.34 | 5.05B |
Pediatrix Medical Group, Inc. engages in the provision of physician services. The company is headquartered in Sunrise, Florida and currently employs 2,150 full-time employees. The Company’s affiliated clinicians provide services to women, babies and children across the continuum of care, both in hospital settings and office-based practices. Its specialties include obstetrics, maternal-fetal medicine and neonatology, complemented by pediatric subspecialties. The company offers specialized and critical care services through approximately 4,400 affiliated physicians and other clinicians. The company provides neonatal clinical care, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. The firm provides maternal-fetal and obstetrical medical care to expectant mothers experiencing complicated pregnancies primarily in areas where its affiliated neonatal physicians practice.
PEDIATRIX MEDICAL GROUP INC
1301 Concord Terrace
Sunrise FLORIDA 33323 US
CEO: Mark S. Ordan
Employees: 2150
Phone: 19543840175
Pediatrix Medical Group, Inc. engages in the provision of physician services. The company is headquartered in Sunrise, Florida and currently employs 2,150 full-time employees. The Company’s affiliated clinicians provide services to women, babies and children across the continuum of care, both in hospital settings and office-based practices. Its specialties include obstetrics, maternal-fetal medicine and neonatology, complemented by pediatric subspecialties. The company offers specialized and critical care services through approximately 4,400 affiliated physicians and other clinicians. The company provides neonatal clinical care, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. The firm provides maternal-fetal and obstetrical medical care to expectant mothers experiencing complicated pregnancies primarily in areas where its affiliated neonatal physicians practice.
The current stock price of MD is 22.34 USD. The price increased by 0.45% in the last trading session.
MD does not pay a dividend.
MD has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
The PE ratio for PEDIATRIX MEDICAL GROUP INC (MD) is 10.95. This is based on the reported non-GAAP earnings per share of 2.04 and the current share price of 22.34 USD.
The Revenue of PEDIATRIX MEDICAL GROUP INC (MD) is expected to decline by -4.52% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
PEDIATRIX MEDICAL GROUP INC (MD) has a market capitalization of 1.92B USD. This makes MD a Small Cap stock.
ChartMill assigns a technical rating of 10 / 10 to MD. When comparing the yearly performance of all stocks, MD is one of the better performing stocks in the market, outperforming 93.89% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to MD. Both the profitability and the financial health of MD get a neutral evaluation. Nothing too spectacular is happening here.
Over the last trailing twelve months MD reported a non-GAAP Earnings per Share(EPS) of 2.04. The EPS increased by 56.92% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 8.44% | ||
| ROA | 7.37% | ||
| ROE | 18.21% | ||
| Debt/Equity | 0.65 |
15 analysts have analysed MD and the average price target is 23.12 USD. This implies a price increase of 3.49% is expected in the next year compared to the current price of 22.34.
For the next year, analysts expect an EPS growth of 44.07% and a revenue growth -4.52% for MD